1. Home
  2. SHBI vs ANNX Comparison

SHBI vs ANNX Comparison

Compare SHBI & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

SELL

Current Price

$22.54

Market Cap

758.9M

Sector

Finance

ML Signal

SELL

Logo Annexon Inc.

ANNX

Annexon Inc.

SELL

Current Price

$3.60

Market Cap

726.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SHBI
ANNX
Founded
1876
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
758.9M
726.1M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SHBI
ANNX
Price
$22.54
$3.60
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
★ $25.60
$15.43
AVG Volume (30 Days)
195.6K
★ 3.0M
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 2.51%
N/A
EPS Growth
★ 34.85
N/A
EPS
★ 1.07
N/A
Revenue
★ $20,853,000.00
N/A
Revenue This Year
$8.92
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$20.86
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$14.93
$2.54
52 Week High
$24.89
$7.18

Technical Indicators

Market Signals
Indicator
SHBI
ANNX
Relative Strength Index (RSI) 43.73 31.79
Support Level $22.47 N/A
Resistance Level $23.17 $4.37
Average True Range (ATR) 0.43 0.22
MACD -0.01 -0.01
Stochastic Oscillator 41.13 13.07

Price Performance

Historical Comparison
SHBI
ANNX

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: